-
$CUBV.0006 - No DILUTION - No NOTES - No DEBTS - 59 Filings... Now you know! Clean Shell!$HDII$MCTC$SNWV$DMAN$RMSL$TNEN$BZTG$IRNC$ACCR$PTAH$AGRX$INKW$KYNC$ZDEC$ALPP$CRDL$XSPT$CYDY$SAML$NDYN$SOAN$APRO$PFMS$DCSR$IGEX$CNNA$DLCR$GRNF$FERN$DLYT$BIPHpic.twitter.com/XJzzNcacXE
-
William Blair Lowers Agile Therapeutics Q2 2020 Earnings Estimates to ($0.10) EPS (Previously ($0.07)). http://zpr.io/tu7XU
$AGRX#AGRX -
William Blair Weighs in on Agile Therapeutics Inc’s FY2021 Earnings
$AGRX http://www.thestockobserver.com/?p=2604918 -
Agile Therapeutics Inc Expected to Post FY2021 Earnings of $0.15 Per Share
$AGRX http://zpr.io/tKvd3 -
-
$AGRX i see this getting anywhere between 6-8 on approval. expect some profit taking, expect large intraday range/swings, take advantage, study chart, watch the spy, make detailed plan!! will not spec on BO price or long term SP. holding through full/partial - you decide!! GL!!! -
Short sale vol (not short interest) for
$TXMD on 2020-01-31 is 64%. http://shortvolumes.com/?t=TXMD$AGRX 57%$PFE 32%$ABBV 47% -
$AGRX Nice size orders coming in -
$AGRX @ $3.80 we’re green -
$GEIN With@GenesysInd 3d printing services, product development is no longer confined by the constraints of lead time and expense http://www.genesysindustries.com/capabilities/#manufacture …$AEMD$HEPA$CHK$GNPX$AGRX$YRCW$VAL$MGEN$NK$DLPH$BIMI$PENN$NNVC$IMGN$CLVS$ANVS$ARAY$MTSI$LB$SCpic.twitter.com/wnIq48pcQ0
-
Brokerages Anticipate Agile Therapeutics Inc
$AGRX to Announce -$0.08 EPS http://dispatchtribunal.com/?p=3215484 -
#estate asset watch - some stocks making 52 wk highs Wednesday -$GE$AAPL$FB$PENN$AGRX$AMX$KNX$AGNC$TNDM$JNJ$RMBS$YNDX$MTSI$MPW$NSC$GSAH$NVS$DOCU$DRE$D$SHOP$FE$LAUR$LXP$TEAM$BRO$HOLX$HRL$CDAY$EVRG$CCI$DHR$BKI$IVR$ADBE$ENB$MMC$APTO$TRP$AMHpic.twitter.com/OjEfNHrTbTWe can help you! Call us in Memphis or GermantownAn experienced attorney for family law, estate law, tax law with offices in Memphis and Germantown. 901-756-7878 -
Agile Therapeutics Announces FDA Extension of Twirla® NDA Review Period
$AGRX https://newsfilter.io/articles/agile-therapeutics-announces-fda-extension-of-twirla-nda-review-period-090582b2ea23218dc6594be9e70c918d … -
FDA extends action date on Agile's Twirla; shares down 39% after hours
$AGRX https://newsfilter.io/articles/fda-extends-action-date-on-agiles-twirla-shares-down-39-after-hours-db3c1f4ce629a9f4fa9bf7a45d02a9f8 …
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.